Retinal health checks using latest technology

Article

Optical Coherence Tomography (OCT) in Age-Related Macular Degeneration (AMD) comes under the spotlight in a new book by Professor Gabriel Coscas.

Optical Coherence Tomography (OCT) in Age-Related Macular Degeneration (AMD) comes under the spotlight in a new book by Professor Gabriel Coscas.

He examines the application of spectral domain OCT and its combination with angiography and also answers many of the questions raised by ophthalmologists following the introduction of the new high resolution OCT devices. There are also new insights and interpretations of retinal diseases.

According to Daniel V. Will, Doody's Review Service, (August, 2009): “This excellent book on age-related macular degeneration is replete with high-resolution images of this complex retinal disease. … Ophthalmology residents and practitioners will benefit from this well organized text-atlas. … This is a very useful text-atlas for ophthalmologists learning to interpret OCT images of patients with age-related macular degeneration. The variety of images and depth of information distinguish this publication from OCT books that focus on a wider spectrum of macular diseases.” To order click here

A second title examining Fundus Autofluorescence by Lois and Forrester is available from Aberdeen at www.fundusautofluorescence.com

Fundus autofluorescence is an emerging imaging modality in both the retinal specialist and generalist practice. It is a non-invasive diagnostic imaging modality that takes advantage of the natural autofluorescence property of the retina. Lipofuscin is a naturally occurring metabolic indicator found in healthy RPE cells. Mapping this compound can provide critical insight to the health of the retina.

Fundus autofluorescence imaging already plays a major role in the diagnosis of dry AMD as well as it serves as predictive factor for the success of the treatment of wet-AMD. Moreover, fundus autofluorescence is being used in pivotal phase 3 trials on drug therapy for dry AMD, which will be an application much bigger then wet-AMD.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.